The 7investing Podcast

Welcome to our 7investing Market Madness competition! Throughout this campaign, we’re matching popular stocks up against one another to determine which will be the best investment over the next three years. And then, by voting in the poll at the bottom of the article, you can help us determine which stock will go on to the next round! Our rankings are determined by the total return of the stock during calendar 2022. The highest-ranked stock had the best overall return of those in our tournament, and our lowest-ranked stock had the lowest overall return. In this first-round matchup, search and AI giant Alphabet (NASDAQ: GOOGL) squares up against the cloud-based continual monitor platform Datadog (NASDAQ: DDOG). Alphabet’s stock fell (38%) in 2022, while Datadog was down (60%). But past performance is not predictive of future returns. Which of these stocks do you believe will provide investors with the best forward three-year return? Read our investing thesis and cast your vote in the poll below! To follow along with our entire Market Madness tournament: ⁠⁠7investing.com/marketmadness⁠⁠ Our Market Madness tournament is in support of our new 7investing Starter membership, which we are giving away free during the entire month of March. To get started with Starter — and to see how we’re already outperforming the S&P 500 by a convincing margin — ⁠⁠click here⁠⁠ to automatically apply your “madness” promo code.

Our "No limit" podcast features 7investing advisors Luke Hallard and Krzysztof Piekarski breaking down investing-related topics. Episode 13 of No Limit focuses entirely on Luke schooling Krzysztof about the banking industry and the reasons and fall-out from the Silicon Valley Bank failure. Krzysztof follows this tutelage with his views on why blockchain technology and smart contracts are a powerful paradigm shift that has become all the more important in response to the lack of stability and transparency in the banking system. https://youtu.be/X3d1m1DRlAw But if banking failures aren’t your cup of Joe, fear not, we talk March Madness and which company we think should win the 7investing tournament vs which company might deliver the best real-world results. Shuffle the deck, deal the cards, good luck to all the players!

Welcome to our 7investing March Madness competition! Throughout this campaign, we’re matching popular stocks up against one another to determine which will be the best investment over the next three years. And then, by voting in the poll at the bottom of the article, you can help us determine which stock will go on to the next round! Our rankings are determined by the total return of the stock during calendar 2022. The highest-ranked stock had the best overall return of those in our tournament, and our lowest-ranked stock had the lowest overall return. In this first-round matchup, i-everything consumer device maker Apple matches up against the social network pioneer Meta Platforms. Both stocks had a challenging 2022: Apple was down (30%) while Meta Platforms fell (63%). But past performance is not predictive of future returns. Which of these stocks do you believe will provide investors with the best forward three-year return? Read our investing thesis and cast your vote in the poll below! To follow along with our entire Market Madness tournament, visit 7investing.com/marketmadness Our Market Madness tournament is in support of our new 7investing Starter membership, which we are giving away free during the entire month of March. To get started with Starter — click here to automatically apply your “madness” promo code.

Welcome to our 7investing March Madness competition! Throughout this campaign, we’re matching popular stocks up against one another to determine which will be the best investment over the next three years. And then, by voting in the poll at the bottom of the article, you can help us determine which stock will go on to the next round! Our rankings are determined by the total return of the stock during calendar 2022. The highest-ranked stock had the best overall return of those in our tournament, and our lowest-ranked stock had the lowest overall return. In this first-round matchup, mRNA and COVID-vaccine developer Moderna (NASDAQ: MRNA) is up against the electric vehicle innovator Tesla (NASDAQ: TSLA). Moderna’s stock fell just (30%) during 2022, while Tesla tumbled (69%). But past performance is not predictive of future returns. Which of these stocks do you believe will provide investors with the best forward three-year return? Read our investing thesis and cast your vote in the poll below! Follow our entire Market Madness tournament at 7investing.com/marketmadness  Our Market Madness tournament is in support of our new 7investing Starter membership, which we are giving away free during the entire month of March. To get started with Starter — and to see how it’s already beating the market significantly — click here to automatically apply your “madness” promo code.

Welcome to our 7investing Market Madness competition! Throughout this campaign, we’re matching popular stocks up against one another to determine which will be the best investment over the next three years. And then, by voting in the poll at the bottom of the article, you can help us determine which stock will go on to the next round! Our rankings are determined by the total return of the stock during calendar 2022. The highest-ranked stock had the best overall return of those in our tournament, and our lowest-ranked stock had the lowest overall return. In this first-round matchup, enterprise software titan Microsoft (NASDAQ: MSFT) takes on the digital financial services innovator SoFi Technologies (NASDAQ: SOFI). Microsoft’s stock fell (29%) during 2022, while SoFi dropped (72%). But past performance is not predictive of future returns. Which of these stocks do you believe will provide investors with the best forward three-year return? Read our investing thesis and cast your vote in the poll below! Follow along with our Market Madness tournament at 7investing.com/marketmadness Our Market Madness tournament is in support of our new 7investing Starter membership, which we are giving away free during the entire month of March. To get started with Starter — and to see how it’s already beating the market by 20 percentage points — click here to automatically apply your “madness” promo code.

Welcome to our 7investing March Madness competition! Throughout this campaign, we’re matching popular stocks up against one another to determine which will be the best investment over the next three years. And then, by voting in the poll at the bottom of the article, you can help us determine which stock will go on to the next round! Our rankings are determined by the total return of the stock during calendar 2022. The highest-ranked stock had the best overall return of those in our tournament, and our lowest-ranked stock had the lowest overall return. In this first-round matchup, the second-seed pharmaceutical powerhouse AbbVie (NYSE: ABBV) is up against the cryptocurrency exchange Coinbase (NASDAQ: COIN).  AbbVie’s stock returned 23% in 2022, while Coinbase’s stock fell (86%). But past performance is not predictive of future returns. Which of these stocks do you believe will provide investors with the best forward three-year return? Read our investing thesis and cast your vote in the poll below! Follow along with our Market Madness tournament at 7investing.com/marketmadness Our Market Madness tournament is in support of our new 7investing Starter membership, which we are giving away free during the entire month of March. To get started with Starter — and to see how it’s already beating the market by 20 percentage points — click here to automatically apply your “madness” promo code.

Welcome to our 7investing Market Madness competition! We are on a quest to find the best current stock opportunity for investors. All month, we’re matching popular stocks up in head-to-head matchups to determine which will provide the greatest upcoming three-year return. And through voting poll we include at the bottom of each article, you can help determine which tock will win each round and ultimately the tournament. In this first-round matchup, the top-ranked energy juggernaut Exxon Mobil (NYSE: XOM) squares up against consumer lending disruptive Upstart (NASDAQ: UPST).  Exxon’s stock returned an impressive 86% during 2022, while Upstart returned a dismal (91%). But past performance is not predictive of future returns. Which of these stocks do you believe will provide investors with the best forward three-year return? Read our investing thesis and cast your vote in the poll below! Follow along with our Market Madness tournament at 7investing.com/marketmadness Our Market Madness tournament is in support of our new 7investing Starter membership, which we are giving away free during the entire month of March. To get started with Starter — and to see how it’s already beating the market by 20 percentage points — click here to automatically apply your “madness” promo code.

No limit episode 12 features Luke’s explanation of his investing framework with Nvidia as a test case that will save you hundreds of future headaches.  We go back to the poker table to poke and prod at the meaning of “priced to perfection” and what to do when one of your stocks is feeling frothy — do you keep betting or do you fold the hand? Krzysztof meanwhile goes to some other kind of casino on the edge of town, where there are no high rollers but only old grizzled hucksters — can there be investing profit made on the fringes? Yes, if you can find reliable sources for who’s who at the table! Luke turns on the boosters and expounds on Orbital Aerospace as a big idea for future investing opportunities: reusable rocketry and low earth orbit is getting sophisticated and essential to the telecommunication industry. Meanwhile back on Earth, Krzysztof talks about his latest read, An Immense World, and the ways we can expand our senses both as human animals and as investors.  It’s another razzle-dazzle kind of show so step right up and push your chips into the pile! Everyone’s a winner at the No Limit 7investing podcast!

7investing CEO Simon Erickson and Marketing Manager JT Street introduce the Market Madness tournament. All month, 7investing will be publishing head-to-head matchups between 16 stocks in order to determine which represents the best current opportunity for investors.  7investing's Twitter account will also post live polls for you to vote on the matchups. And also host Spaces episodes to discuss the stocks with a live audience.  The tournament will run for the first three weeks of March and will support our new 7investing Starter membership. Starter is our lower-priced service, which offers two stock recommendations and Deep Dives for $17 per month. It's a great way to get started on a lifelong investing journey and to get introduced to 7investing's advisors, content, and investing approach. Learn more about 7investing.com/starter-membership. We'll be posting our Spaces episodes to our podcast all month. Welcome to 7investing's Market Madness!

It's relatively easy to argue that some type of exposure to emerging markets belongs in most U.S. investor portfolios. Emerging markets represent about 4.3 billion people, 50% of the global GDP, but only a relatively small percentage of global equities' market cap. Emerging markets are usually defined as a country with a developing economy that shares some, but not all, characteristics with a developed economy. To discuss emerging markets more, 7investing lead advisor Matthew Cochrane welcomed Perth Tolle, the founder of Life and Liberty Indexes, to 7investing's podcast. The two coincidentally talked on February 24, 2023, the first anniversary of the Russian invasion of Ukraine. As the conflict began, U.S. investors were forced to quickly confront the geopolitical risks of investing in emerging markets as Russian equities were removed from the emerging market indices at $0. Investors in Tolle's Freedom 100 Emerging Markets ETF (CBOE:FRDM) didn't face this problem as the ETF had no exposure to Russian securities. The ETF is a freedom-weighted equity strategy that uses personal and economic freedom metrics as primary factors in its investment process. This means it doesn't have heavy exposure to countries such as China or Russia, markets that traditionally hold larger allocations in emerging market funds. Tolle and Cochrane discuss that even as China's GDP growth has exploded in recent decades, shareholders in Chinese equities have managed to capture very little of that wealth. With China's government in virtually total control of its economy, it can change laws and regulations on a dime. It will often dictate new rules for businesses as it deems fit. This environment makes it very difficult for shareholders to recognize any profits. Tolle and Cochrane also discuss emerging markets that enjoy economic and personal freedoms, such as Chile, South Korea, and Taiwan. Exposure to Chilean markets, for instance, rarely rises above 1% allocations in most emerging market funds. The Freedom ETF enjoys a double-digit allocation that has tremendously boosted FRDM's returns compared to the emerging market index, contributing to Freedom's relative out-performance. To get our investing podcasts and articles delivered to your Inbox every day, join our 7investing email list at 7investing.com/email.